Source comparison
Adamax vs Semax Amidate: Direct Comparison
Choosing between Adamax and Semax Amidate requires understanding not just what each peptide does, but which cellular pathways your research protocol is designed to interrogate. The table below maps the critical differentiators across mechanism, receptor target
This comparison does not assign a generated winner or score.
- Choosing between Adamax and Semax Amidate requires understanding not just what each peptide does, but which cellular pathways your research protocol is designed to interrogate. The table below maps the critical differentiators across mechanism, receptor targets, research applications, and practical considerations that determine which peptide aligns with specific experimental designs.
- Primary Mechanism
- Melanocortin receptor agonism (MC3/MC4)
- BDNF gene upregulation via promoter IV activation
- Determines which cellular pathway is activated
- Non-overlapping. Cannot substitute one for the other
- Receptor Target
- G-protein coupled MC receptors
- TrkB neurotrophin receptors (indirect via BDNF)
- Defines whether effects require melanocortin system
- Adamax needs MC expression; Semax works without it
- Onset of Action
- 15–30 minutes (cAMP elevation)
- 2–4 hours (BDNF transcription lag)
- Shapes acute vs sustained intervention designs
- Adamax for rapid signaling; Semax for delayed plasticity
- Duration of Effect
- 2–4 hours (requires multiple daily doses)
- 12–24 hours (single or twice-daily dosing sufficient)
- Impacts dosing frequency and chronic study logistics
- Semax Amidate requires less frequent administration
- Metabolic Effects
- Direct: reduces food intake, increases energy expenditure
- Minimal to none at cognitive research doses
- Separates metabolic vs pure cognitive research
- Only Adamax addresses melanocortin metabolic pathways
- Neuroprotection Mechanism
- MC4-mediated cAMP/PKA/CREB pathway
- BDNF-TrkB activation of MAPK, PI3K, PLCγ cascades
- Different molecular targets for injury models
- Both neuroprotective through distinct mechanisms
- Blood-Brain Barrier
- Partial permeability (better with intranasal)
- High permeability (crosses efficiently via peripheral routes)
- Affects route of administration in in vivo models
- Semax Amidate more reliably reaches CNS tissue
- Typical Research Dose (Rodent)
- 0.5–2.0 mg/kg, multiple daily doses
- 0.1–0.5 mg/kg, once or twice daily
- Dose ranges not interchangeable
- Lower doses for Semax due to longer half-life
- Storage Requirement
- Lyophilized: −20°C; reconstituted: 2–8°C, 28 days
- Identical cold chain requirements
- Both require identical storage protocols
- Primary Research Use
- Melanocortin-metabolic-cognitive intersection studies
- BDNF-mediated neuroplasticity and neuroprotection
- Determines which hypothesis each peptide can test
- Adamax for MC pathways; Semax for neurotrophin signaling